These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7449292)

  • 1. Asymptomatic mild hyperuricaemia: an indicator of nephrosclerosis in essential hypertension.
    Messerli FH; Frohlich ED; Dreslinski GR; Suarez DH; Aristimuno GG
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():409s-410s. PubMed ID: 7449292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum uric acid in essential hypertension: an indicator of renal vascular involvement.
    Messerli FH; Frohlich ED; Dreslinski GR; Suarez DH; Aristimuno GG
    Ann Intern Med; 1980 Dec; 93(6):817-21. PubMed ID: 7447188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal damage in hypertension.
    Ruilope LM
    J Cardiovasc Risk; 1995 Feb; 2(1):40-4. PubMed ID: 7606639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperuricemia in essential hypertension. Considerations on some pathogenic aspects].
    Guerrera G; Melina D; Cocco F
    Minerva Med; 1983 Mar; 74(11):525-30. PubMed ID: 6835545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis.
    Momoki K; Kataoka H; Moriyama T; Mochizuki T; Nitta K
    J Atheroscler Thromb; 2017 Jun; 24(6):630-642. PubMed ID: 27784849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid and nocturnal nondipping in hypertensive patients with normal renal function.
    Afsar B; Elsurer R; Ozdemir FN; Sezer S
    J Nephrol; 2008; 21(3):406-11. PubMed ID: 18587730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function.
    Scaglione R; Ganguzza A; Corrao S; Parrinello G; Merlino G; Dichiara MA; Arnone S; D'Aubert MD; Licata G
    Int J Obes Relat Metab Disord; 1995 Jun; 19(6):403-9. PubMed ID: 7550525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
    Ono H; Ono Y; Frohlich ED
    Hypertension; 1996 Feb; 27(2):176-83. PubMed ID: 8567038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid as a cardiovascular risk factor in arterial hypertension.
    Puig JG; Ruilope LM
    J Hypertens; 1999 Jul; 17(7):869-72. PubMed ID: 10419058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperfiltration and conservation of renal function in hypertensive nephrosclerosis patients.
    Lee HC; Mitchell HC; Van Dreal P; Pettinger WA
    Am J Kidney Dis; 1993 Apr; 21(4 Suppl 1):68-74. PubMed ID: 8465839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in hemodynamic parameters and volume homeostasis with the menstrual cycle among women with a history of preeclampsia.
    Spaanderman ME; Van Beek E; Ekhart TH; Van Eyck J; Cheriex EC; De Leeuw PW; Peeters LL
    Am J Obstet Gynecol; 2000 May; 182(5):1127-34. PubMed ID: 10819846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular Density in Biopsy-Proven Hypertensive Nephrosclerosis.
    Haruhara K; Tsuboi N; Kanzaki G; Koike K; Suyama M; Shimizu A; Miyazaki Y; Kawamura T; Ogura M; Yokoo T
    Am J Hypertens; 2015 Sep; 28(9):1164-71. PubMed ID: 25631380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertensive nephrosclerosis.
    Hill GS
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):266-70. PubMed ID: 18408477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal involvement follows cardiac enlargement in essential hypertension.
    Kobrin I; Frohlich ED; Ventura HO; Messerli FH
    Arch Intern Med; 1986 Feb; 146(2):272-6. PubMed ID: 2936314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of varying perfusion pressures on the output of sodium and renin and the vascular resistance in kidneys of rats with "post-salt" hypertension and Kyoto spontaneous hypertension.
    Tobian L; Johnson MA; Lange J; Magraw S
    Circ Res; 1975 Jun; 36(6 Suppl 1):162-70. PubMed ID: 1132075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrochlorothiazide exacerbates nitric oxide-blockade nephrosclerosis with glomerular hypertension in spontaneously hypertensive rats.
    Ono Y; Ono H; Frohlich ED
    J Hypertens; 1996 Jul; 14(7):823-8. PubMed ID: 8818920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats.
    Nakamura Y; Ono H; Frohlich ED
    Hypertension; 1999 Aug; 34(2):273-8. PubMed ID: 10454453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal parenchymal involvement in essential hypertension.
    Schwartz GL; Strong CG
    Med Clin North Am; 1987 Sep; 71(5):843-58. PubMed ID: 3306206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperuricaemia is associated with renal damage independently of hypertension and intrarenal renin-angiotensin system activation, as well as their circadian rhythms.
    Ohashi N; Ishigaki S; Isobe S; Tsuji N; Iwakura T; Ono M; Tsuji T; Sakao Y; Kato A; Yasuda H
    Nephrology (Carlton); 2015 Nov; 20(11):814-9. PubMed ID: 25968901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.